Cargando…
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements
The common IVSI-110 (G>A) β-thalassemia mutation is a paradigm for intronic disease-causing mutations and their functional repair by non-homologous end joining-mediated disruption. Such mutation-specific repair by disruption of aberrant regulatory elements (DARE) is highly efficient, but to date,...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912506/ https://www.ncbi.nlm.nih.gov/pubmed/31766235 http://dx.doi.org/10.3390/jcm8111959 |